VICC THO 0746 - A Phase I/II Study of Nab-Paclitaxel [paclitaxel] and Carboplatin With Concurrent Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer (NSCLC).

Trial Profile

VICC THO 0746 - A Phase I/II Study of Nab-Paclitaxel [paclitaxel] and Carboplatin With Concurrent Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer (NSCLC).

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 01 May 2015

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Nov 2011 Planned end date changed from 1 Jan 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
    • 17 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 May 2011 Status changed from suspended to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top